 plasma exchang chronic progress multipl sclerosi long-term studi plasma exchang PE previou double-blind studi signific addit benefit year patient chronic progress multipl sclerosi cpm immunosuppress drug therapi isdt efficaci extend term indic retreat long-term toxic analysi number patient past year patient cpm PE low-dos isdt center improv kurtzk disabl statu scale step post-therapi follow-up signific comparison pre-p disabl statu clinic improv major patient follow-up major life-threaten complic attribut therapi